Kiniksa Pharmaceuticals International Plc (KNSA) Unusual Options Activity Today

Checking KNSA unusual options activity helps you spot when traders are making outsized bets on Kiniksa Pharmaceuticals International Plc before the broader market catches on. Kiniksa Pharmaceuticals International Plc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor KNSA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching KNSA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking KNSA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and KNSA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response.

Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.

Catalysts rarely arrive without a footprint, and KNSA unusual options activity is often where that footprint shows up first. Our scanner tracks Kiniksa Pharmaceuticals International Plc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at KNSA unusual options volume on the call side or chasing put sweeps, Kiniksa Pharmaceuticals International Plc's unusual options flow today is one click away, so put it on your radar before the headlines hit.